Dear Members of the ESC Working Group on Atherosclerosis and Vascular Biology,
We hope that you had a refreshing summer break and enjoyed the ESC Congress 2021 – The Digital Experience – held online at the end of August. During this ESC congress, two researchers won the awards in the field of Atherosclerosis and Vascular Biology: Hauke Horstmann (Germany) for his study entitled “Integrative single cell RNA-sequencing descrambles a substantial divergence of adaptive immune cell identities and transcriptional programs in mouse and human atherosclerosis” and Christine Cheung (Singapore) for her study entitled “Endothelial-T cell crosstalk contributes to vascular injury in fatty liver disease”. We warmly congratulate them for their brilliant presentation.
We would also like to grasp this opportunity to warmly congratulate Prof. Paul Evans (University of Sheffield, Sheffield, UK), our Working Group chairman from 2016 to 2018, and Prof. Giovanni Camici (University of Zurich, Switzerland), who both received the Outstanding Achievement Award from the Council on Basic Cardiovascular Science (CBCS).
In this issue of the Newsletter, we present recommended readings in addition to a commented article on PCSK9: “PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction”, recently published in the European Heart Journal by Norata and colleagues. This outstanding publication sheds light on the role of PCSK9 deficiency in cardiac lipid metabolism and development of heart failure with preserved ejection fraction.
On behalf of the Nucleus Members of the Working Group on Atherosclerosis and Vascular Biology, we hope you find the articles we handpicked for you to be of great interest.
Konstantinos Stellos, Communication Coordinator
Marie-Luce Bochaton-Piallat, Chairperson
Our mission: To reduce the burden of cardiovascular disease.